JPWO2020181050A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020181050A5 JPWO2020181050A5 JP2021552747A JP2021552747A JPWO2020181050A5 JP WO2020181050 A5 JPWO2020181050 A5 JP WO2020181050A5 JP 2021552747 A JP2021552747 A JP 2021552747A JP 2021552747 A JP2021552747 A JP 2021552747A JP WO2020181050 A5 JPWO2020181050 A5 JP WO2020181050A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- syndrome
- compound
- item
- alkylenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962814025P | 2019-03-05 | 2019-03-05 | |
| US62/814,025 | 2019-03-05 | ||
| US201962879178P | 2019-07-26 | 2019-07-26 | |
| US62/879,178 | 2019-07-26 | ||
| PCT/US2020/021120 WO2020181050A1 (en) | 2019-03-05 | 2020-03-05 | Compounds, compositions, and methods for the treatment of disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525010A JP2022525010A (ja) | 2022-05-11 |
| JPWO2020181050A5 true JPWO2020181050A5 (ko) | 2023-03-13 |
Family
ID=72338059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021552747A Pending JP2022525010A (ja) | 2019-03-05 | 2020-03-05 | 疾患の治療のための化合物、組成物、及び方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20220168309A1 (ko) |
| EP (1) | EP3934652A4 (ko) |
| JP (1) | JP2022525010A (ko) |
| KR (1) | KR20210135544A (ko) |
| CN (1) | CN113645977A (ko) |
| AU (1) | AU2020232761A1 (ko) |
| BR (1) | BR112021017583A2 (ko) |
| CA (1) | CA3131620A1 (ko) |
| CL (1) | CL2021002294A1 (ko) |
| CO (1) | CO2021012586A2 (ko) |
| CR (1) | CR20210508A (ko) |
| DO (1) | DOP2021000184A (ko) |
| EC (1) | ECSP21073266A (ko) |
| IL (1) | IL285782A (ko) |
| JO (1) | JOP20210244A1 (ko) |
| MA (1) | MA55214A (ko) |
| MX (1) | MX2021010701A (ko) |
| PE (1) | PE20220166A1 (ko) |
| SG (1) | SG11202109452SA (ko) |
| WO (1) | WO2020181050A1 (ko) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113490668A (zh) | 2018-10-05 | 2021-10-08 | 安娜普尔纳生物股份有限公司 | 用于治疗与apj受体活性有关的疾病的化合物和组合物 |
| BR112021016620A2 (pt) | 2019-02-27 | 2021-11-03 | Univ California | Azepino-indóis e outros heterociclos para o tratamento de distúrbios cerebrais |
| JP2022543086A (ja) | 2019-08-02 | 2022-10-07 | メルサナ セラピューティクス インコーポレイテッド | がんの処置用のＳＴＩＮＧ（インターフェロン遺伝子刺激因子）アゴニストとしてのビス－［Ｎ－（（５－カルバモイル）－１Ｈ－ベンゾ［ｄ］イミダゾール－２－イル）－ピラゾール－５－カルボキサミド］誘導体および関連化合物 |
| WO2021226261A1 (en) | 2020-05-06 | 2021-11-11 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| WO2022034474A1 (en) * | 2020-08-10 | 2022-02-17 | Novartis Ag | Treatments for retinal degenerative diseases |
| US11767321B2 (en) | 2020-10-05 | 2023-09-26 | Enliven Inc. | 5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases |
| CN114478715B (zh) * | 2020-10-26 | 2023-12-22 | 南京吉芮康生物科技研究院有限公司 | 一种减毒沙门氏菌分泌表达s2结构域蛋白的新型冠状病毒疫苗递呈系统及其应用 |
| US11964978B2 (en) * | 2021-03-18 | 2024-04-23 | Pfizer Inc. | Modulators of STING (stimulator of interferon genes) |
| WO2022266711A1 (en) * | 2021-06-23 | 2022-12-29 | Aculeus Therapeutics Pty Ltd | Substituted amidobenzimidazole dimers as sting modulators |
| AU2022388555A1 (en) | 2021-11-09 | 2024-05-02 | Ajax Therapeutics, Inc. | 6-he tero aryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
| WO2024118785A2 (en) | 2022-11-30 | 2024-06-06 | Regeneron Pharmaceuticals, Inc. | Tlr7 agonists and antibody-drug-conjugates thereof |
| CN115624616B (zh) * | 2022-12-21 | 2023-03-14 | 上海市东方医院（同济大学附属东方医院） | 接头蛋白pinch在诊断血管发育异常相关疾病中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6110923A (en) * | 1994-06-22 | 2000-08-29 | Biochem Pharma Inc. | Method for treating cancer using novel substituted purinyl derivatives with immunomodulating activity |
| US6770651B2 (en) * | 2001-06-29 | 2004-08-03 | Venkata Palle | A2B adenosine receptor antagonists |
| WO2010017248A2 (en) * | 2008-08-04 | 2010-02-11 | University Of Miami | Sting (stimulator of interferon genes), a regulator of innate immune responses |
| SG11201607586UA (en) * | 2014-03-13 | 2016-10-28 | Agency Science Tech & Res | Fused pyrimidine-based hydroxamate derivatives |
| GB201501462D0 (en) * | 2015-01-29 | 2015-03-18 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
-
2020
- 2020-03-05 MA MA055214A patent/MA55214A/fr unknown
- 2020-03-05 AU AU2020232761A patent/AU2020232761A1/en not_active Abandoned
- 2020-03-05 CR CR20210508A patent/CR20210508A/es unknown
- 2020-03-05 US US17/435,830 patent/US20220168309A1/en active Pending
- 2020-03-05 PE PE2021001442A patent/PE20220166A1/es unknown
- 2020-03-05 JP JP2021552747A patent/JP2022525010A/ja active Pending
- 2020-03-05 CA CA3131620A patent/CA3131620A1/en active Pending
- 2020-03-05 JO JOP/2021/0244A patent/JOP20210244A1/ar unknown
- 2020-03-05 KR KR1020217031526A patent/KR20210135544A/ko unknown
- 2020-03-05 WO PCT/US2020/021120 patent/WO2020181050A1/en unknown
- 2020-03-05 SG SG11202109452SA patent/SG11202109452SA/en unknown
- 2020-03-05 CN CN202080018688.XA patent/CN113645977A/zh active Pending
- 2020-03-05 EP EP20766192.7A patent/EP3934652A4/en not_active Withdrawn
- 2020-03-05 BR BR112021017583A patent/BR112021017583A2/pt not_active IP Right Cessation
- 2020-03-05 MX MX2021010701A patent/MX2021010701A/es unknown
-
2021
- 2021-08-22 IL IL285782A patent/IL285782A/en unknown
- 2021-09-02 CL CL2021002294A patent/CL2021002294A1/es unknown
- 2021-09-03 DO DO2021000184A patent/DOP2021000184A/es unknown
- 2021-09-24 CO CONC2021/0012586A patent/CO2021012586A2/es unknown
- 2021-10-01 EC ECSENADI202173266A patent/ECSP21073266A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020181050A5 (ko) | ||
| US20220168309A1 (en) | Compounds, compositions, and methods for the treatment of disease | |
| ES2737696T3 (es) | Pirazolopiridinas y pirazolopirimidinas | |
| RU2016110852A (ru) | Ингибиторы irak и их применения | |
| IL277069A (en) | Transformed aminopurine compounds, their compositions and methods of treatment with them | |
| EP2970267B3 (en) | P2x7 modulators | |
| RU2016140870A (ru) | Ингибиторы irak и их применения | |
| CA3059939A1 (en) | Indole ahr inhibitors and uses thereof | |
| AU2020325477A1 (en) | Tetracyclic compound, preparation method therefor and use thereof | |
| US11008302B2 (en) | Substituted pyridine and pyrimidines and their use as GluN2B receptor modulators | |
| CA2969587A1 (en) | Compounds for treating cystic fibrosis | |
| AU2020240382B2 (en) | Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective component | |
| ES2574840T3 (es) | Derivados de amidas heterocíclicas como antagonistas de receptores p2x7 | |
| JP2015503618A5 (ko) | ||
| US10150766B2 (en) | P2X7 modulators | |
| JP2017502088A5 (ko) | ||
| PL188077B1 (pl) | Podstawione 1-fenylopirazolo-3-karboksyamidy jakosubstancje aktywne wobec receptorów neurotensyny,ich wytwarzanie i zawierające je kompozycje farmaceutyczne | |
| IL227251A (en) | History of Pipridine Bridges | |
| CA2588463A1 (en) | 3-substituted pyridine derivatives as h3 antagonists | |
| CA2824415A1 (en) | Benzamide derivatives as p2x7 receptor antagonists | |
| AU2005228845A1 (en) | Compositions useful as inhibitors of protein kinases | |
| JPWO2020113233A5 (ko) | ||
| PT1943243E (pt) | Inibidores de cinase | |
| ES2616883T3 (es) | Derivados amida heterocíclicos como antagonistas del receptor P2X7 | |
| JP7367004B2 (ja) | 自己免疫疾患の処置のための新規のピラゾロビリジン化合物 |